s42909
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2017 (NCT03077165)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cytochrome b-245 heavy chainINHIBITOR
CYBB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s42909
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03077165 | Phase 2 | May 1, 2017 | Ilkos Therapeutic Inc., University of Bonn |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ilkos Therapeutic Inc. | For profit | 1 | 1 | 1 | 2017 |
| University of Bonn | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1